Scarnose International announces book closure for 15th AGM
- Book closure runs from September 9 to September 16, 2026
- 15th AGM scheduled for September 16, 2026 via video conference
- Cut-off for e-voting eligibility is September 9, 2026
- Three related-party transactions seek shareholder approval

*this image is generated using AI for illustrative purposes only.
Scarnose International Limited has announced the book closure period for its 15th Annual General Meeting (AGM). The company’s register of members and share transfer books will remain closed from September 9, 2026 to September 16, 2026 (both days inclusive).
The closure is intended to determine shareholders eligible to receive the AGM notice and those entitled to participate in e-voting. The cut-off date for determining shareholders for sending the notice is August 14, 2026, while the cut-off for e-voting eligibility is September 9, 2026.
Meeting Details
The 15th AGM is scheduled for September 16, 2026, at 4:00 pm. The meeting will be conducted through video conference or other audio-visual means. The Board of Directors approved the notice for the AGM and the Director’s Report during a meeting held on August 19, 2026.
Related-Party Transactions
The board considered and recommended three material related-party transactions for approval by shareholders at the ensuing AGM. These transactions were previously approved by the Audit Committee.
The proposed transactions involve:
- Dada Organics Limited
- Dadaji Lifescience Private Limited
- Add-Shop E-Retail Limited
Corporate Governance
The board meeting commenced at 5:00 pm and concluded at 7:00 pm at the company’s registered office in Rajkot, Gujarat. The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Shraddha Dev Pandya, Managing Director, signed the disclosure letter addressed to BSE Limited.
Historical Stock Returns for Scarnose International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | -10.34% | 0.0% | -43.37% | 0.0% |
What specific strategic objectives or financial benefits are driving the proposed related-party transactions with Dada Organics, Dadaji Lifescience, and Add-Shop E-Retail?
How might the approval of these material related-party transactions impact Scarnose International's future revenue streams and operational synergies?
Are there any potential conflicts of interest or governance concerns associated with these transactions that shareholders should scrutinize during the AGM?





























